Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Endocrine reviews

• Publication date

  2000-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/EDRV.21.3.0398PMID 10857554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hydrometrocolpos following prenatal dexamethasone treatment for congenital adrenal hyperplasia (21-hydroxylase deficiency)

  2005cited by this paper
• Testicular adrenal-like tissue (TALT) in congenital adrenal hyperplasia: Detection by ultrasonography

  2005cited by this paper
• Diagnosis, prognosis and management of incidentally found prostate cancer

  2004cited by this paper
• Macronodular congenital adrenal hyperplasia in an adult with female pseudohermaphroditism

  2004cited by this paper
• Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia.

  2000cited by this paper
• Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency.

  1999cited by this paper
• Mutation distribution and CYP21/C4 locus variability in Brazilian families with the classical form of the 21‐hydroxylase deficiency

  1999cited by this paper
• Toward better treatment of congenital adrenal hyperplasia*

  1999cited by this paper
• Optimizing the diagnostic criteria for standard (250-microg) and low dose (1-microg) adrenocorticotropin tests in the assessment of adrenal function.

  1999cited by this paper
• New insights into the t‐complex and control of sperm function

  1999cited by this paper
• Effects of early androgens on sex-typed activities and interests in adolescents with congenital adrenal hyperplasia.

  1999cited by this paper
• Resequencing and mutational analysis using oligonucleotide microarrays

  1999cited by this paper
• Profiling steroid hormones in amniotic fluid of midpregnancy by routine stable isotope dilution/gas chromatography-mass spectrometry: reference values and concentrations in fetuses at risk for 21-hydroxylase deficiency.

  1999cited by this paper
• Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

  1999cited by this paper
• Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia.

  1999cited by this paper
• Optimizing the Diagnostic Criteria for Standard (250-μg) and low Dose (1-μg) Adrenocorticotropin Tests in the Assessment of Adrenal Function

  1999cited by this paper
• Effects of missense mutations and deletions on membrane anchoring and enzyme function of human steroid 21-hydroxylase (P450c21).

  1999cited by this paper
• Congenital adrenal hyperplasia in the adult patient.

  1999cited by this paper
• Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease.

  1999cited by this paper
• Prenatal treatment of congenital adrenal hyperplasia.

  1999influential reference
• Dehydroepiandrosterone replacement in women with adrenal insufficiency.

  1999cited by this paper
• Clinical utility of adrenal ultrasonography in the diagnosis of congenital adrenal hyperplasia.

  1999cited by this paper
• Genetic diagnosis of 21‐hydroxylase deficiency: DGGE‐based mutation scanning of CYP21

  1999cited by this paper
• Effect of newborn screening for congenital adrenal hyperplasia.

  1999cited by this paper
• Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations.

  1999cited by this paper
• Characterization of single-nucleotide polymorphisms in coding regions of human genes

  1999cited by this paper
• A novel frameshift mutation (141delT) in exon 1 of the 21-hydroxylase gene (CYP21) in a patient with the salt wasting form of congenital adrenal hyperplasia. Mutation in brief no. 255. Online.

  1999cited by this paper
• Congenital adrenal hyperplasia in the adult patient.

  1999cited by this paper
• Home monitoring of 17 hydroxyprogesterone levels in congenitx127drenal hyperplasia with filter paper blood samples.

  1999cited by this paper
• Screening for mutations of 21-hydroxylase gene in Hungarian patients with congenital adrenal hyperplasia.

  1999cited by this paper
• Low frequency of CYP2B deletions in Brazilian patients with congenital adrenal hyperplasia due to 21-hydroxylas deficiency.

  1999cited by this paper
• The role of androgens in male gender role behavior.

  1999cited by this paper
• Female Development in Mammals is Regulated by Wnt-4-Signaling

  1999cited by this paper
• Characterization of the consequence of a novel Glu-380 to Asp mutation by expression of functional P450c21 in Escherichia coli.

  1999cited by this paper
• P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5.

  1999cited by this paper
• Adrenomedullary function is severely impaired in 21‐hydroxylase‐deficient mice

  1999cited by this paper
• Single-nucleotide polymorphisms in intron 2 of CYP21P: evidence for a higher rate of mutation at CpG dinucleotides in the functional steroid 21-hydroxylase gene and application to segregation analysis in congenital adrenal hyperplasia.

  1999cited by this paper
• Gene interactions in gonadal development.

  1999cited by this paper
• A novel frameshift mutation (141delT) in exon 1 of the 21‐hydroxylase gene (CYP21) in a patient with the salt wasting form of congenital adrenal hyperplasia

  1999cited by this paper
• Fluorescent PCR and automated fragment analysis in preimplantation genetic diagnosis for 21-hydroxylase deficiency in congenital adrenal hyperplasia.

  1999cited by this paper
• Congenital adrenal hyperplasia: molecular genetics and alternative approaches to treatment.

  1999cited by this paper
• A novel missense mutation, GLY424SER, in Brazilian patients with 21-hydroxylase deficiency.

  1999cited by this paper
• A Novel Frameshift Mutation in the First Exon of the 21-OH Gene Found in Homozygosity in an Apparently Nonconsanguineous Family

  1999cited by this paper
• Effect of carbenoxolone on the plasma renin activity and hypothalamic–pituitary–adrenal axis in congenital adrenal hyperplasia due to 21‐hydroxylase deficiency*

  1999cited by this paper
• Identification of CYP21 mutations, one novel, by single strand conformational polymorphism (SSCP) analysis

  1999cited by this paper
• 21-hydroxylase deficiency in Italy: a distinct distribution pattern ofCYP21 mutations in a sample from southern Italy

  1999cited by this paper
• Pediatric management of ambiguous and traumatized genitalia.

  1999cited by this paper
• What causes low rates of child-bearing in congenital adrenal hyperplasia?

  1999cited by this paper
• Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia.

  1999cited by this paper
• Testicular adrenal rest tissue in congenital adrenal hyperplasia: serial sonographic and clinical findings.

  1999cited by this paper
• Female development in mammals is regulated by Wnt-4 signalling

  1999cited by this paper
• [Neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Lille experience 1980-1996].

  1999cited by this paper
• Mutation Analysis in Patients with Congenital Adrenal Hyperplasia in the Spanish Population: Identification of Putative Novel Steroid 21-Hydroxylase Deficiency Alleles Associated with the Classic Form of the Disease

  1999cited by this paper
• Mutation screening in British 21-hydroxylase deficiency families and development of novel microsatellite based approaches to prenatal diagnosis

  1999cited by this paper
• Functional analysis of four CYP21 mutations from spanish patients with congenital adrenal hyperplasia.

  1999cited by this paper
• Prenatal Diagnosis and Treatment of 11β-Hydroxylase Deficiency Congenital Adrenal Hyperplasia Resulting in Normal Female Genitalia1

  1999cited by this paper
• Modular Variations of the Human Major Histocompatibility Complex Class III Genes for Serine/Threonine Kinase RP, Complement Component C4, Steroid 21-Hydroxylase CYP21, and Tenascin TNX (the RCCX Module)

  1999cited by this paper
• Low Frequency of CYP21B Deletions in Brazilian Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

  1999cited by this paper
• Inflammatory bowel disease in children and adolescents: mental health and family functioning.

  1999cited by this paper
• Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations.

  1999cited by this paper
• Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11beta-hydroxysteroid dehydrogenase reductase activity.

  1999cited by this paper
• Gender assignment and reassignment in 46,XY pseudohermaphroditism and related conditions.

  1999cited by this paper
• Characterization of single-nucleotide polymorphisms in coding regions of human genes

  1999cited by this paper
• Feminizing genitoplasty for congenital adrenal hyperplasia: what happens at puberty?

  1999cited by this paper
• HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.

  1999cited by this paper
• Experiment of Nurture: Ablatio Penis at 2 Months, Sex Reassignment at 7 Months, and a Psychosexual Follow-up in Young Adulthood

  1998cited by this paper
• Intersexuality: What Should Careproviders Do Now

  1998cited by this paper
• Normal external genitalia in a female with classical congenital adrenal hyperplasia who was not treated during embryogenesis

  1998cited by this paper
• Genotype‐phenotype analysis in late onset 21‐hydroxylase deficiency in comparison to the classical forms

  1998cited by this paper
• Prenatal treatment of congenital adrenal hyperplasia: a commentary.

  1998cited by this paper
• HIV prevention among injecting drug users: responses in developing and transitional countries.

  1998cited by this paper
• Molecular genetics of congenital adrenal hyperplasia (21‐hydroxylase deficiency): implications for diagnosis, prognosis and treatment

  1998cited by this paper
• Structure and Function of the Peripheral-Type Benzodiazepine Receptor in Steroidogenic Cells

  1998cited by this paper
• Naturally Occurring Mutants of Human Steroid 21-Hydroxylase (P450c21) Pinpoint Residues Important for Enzyme Activity and Stability*

  1998cited by this paper
• A comparative cost analysis of newborn screening for classic congenital adrenal hyperplasia in Texas.

  1998cited by this paper
• Results of Screening 1.9 Million Texas Newborns for 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia

  1998influential reference
• Should We Monitor More Closely the Dosage of 9α-Fluorohydrocortisone in Salt-losing Congenital Adrenal Hyperplasia?

  1998cited by this paper
• The -104G nucleotide of the human CYP21 gene is important for CYP21 transcription activity and protein interaction.

  1998influential reference
• Protein kinase A, protein kinase C, and Ca(2+)-regulated expression of 21-hydroxylase cytochrome P450 in H295R human adrenocortical cells.

  1998cited by this paper
• Study of a kindred with classic congenital adrenal hyperplasia: diagnostic challenge due to phenotypic variance.

  1998cited by this paper
• Prominent sex steroid metabolism in human lymphocytes.

  1998cited by this paper
• Identification of heterozygotic carriers of 21-hydroxylase deficiency: sensitivity of ACTH stimulation tests.

  1998cited by this paper
• The influence of prenatal dexamethasone treatment on urinary excretion of adrenocortical steroids in newborns

  1998cited by this paper
• Prenatal treatment of congenital adrenal hyperplasia: a promising experimental therapy of unproven safety.

  1998cited by this paper
• Final height after combined growth hormone and gonadotrophin‐releasing hormone analogue therapy in short healthy children entering into normally timed puberty

  1998cited by this paper
• Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.

  1998cited by this paper
• Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.

  1998cited by this paper
• Molecular genetic analysis of patients carrying steroid 21-hydroxylase deficiency in the Mexican population: identification of possible new mutations and high prevalence of apparent germ-line mutations

  1998cited by this paper
• Adrenal incidentalomas: adrenal hemangioma in a patient with congenital adrenal hyperplasia.

  1998cited by this paper
• Cellular and extracellular regulatory mechanisms of hypothalamic corticotropin-releasing hormone neurons.

  1998cited by this paper
• Congenital adrenal hyperplasia. Molecular characterization.

  1998cited by this paper
• Prenatal diagnosis of steroid 21-hydroxylase deficiency by the modified polymerase chain reaction to detect splice site mutation in the CYP21 gene.

  1998cited by this paper
• Benefits of Neonatal Screening for Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency) in Sweden

  1998cited by this paper
• Pediatric Ethics and the Surgical Assignment of Sex

  1998cited by this paper
• Obesity in 21-hydroxylase deficient patients

  1998cited by this paper
• Glucocorticoid administration alters nuclear transcription factors in fetal rat brain: implications for the use of antenatal steroids.

  1998cited by this paper
• Dax1 antagonizes Sry action in mammalian sex determination

  1998cited by this paper
• Identification of four novel mutations in the CYP21 gene in congenital adrenal hyperplasia in the Chinese

  1998cited by this paper
• DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging.

  1998cited by this paper
• Long-Term Psychological Evaluation of Intersex Children

  1998cited by this paper

• Clinical Application of Steroid Profiles and Their Interpretation in Adrenal Disorders

  2026cites this paper
• SDrecall: a sensitive approach for variant detection in segmental duplications

  2026cites this paper
• Standardized multidisciplinary care for children and adolescents with differences of sex development: a health intelligence approach.

  2026cites this paper
• Male sex assignment in severely virilized 46,XX children with congenital adrenal hyperplasia

  2026cites this paper
• Molecular Landscape of Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency in India.

  2026cites this paper
• Adrenal Venous Sampling Aids in Distinguishing 17-Hydroxyprogesterone Hypersecreting Adrenal Cortical Adenomas from Non-Classical 21-Hydroxylase Deficiency

  2026cites this paper
• Comprehensive adrenal steroid profiling during frog metamorphosis.

  2025cites this paper
• Immunophenotypic Implications of Reverse-Circadian Glucocorticoid Treatment in Congenital Adrenal Hyperplasia

  2025cites this paper
• Final Heights in Patients with Congenital Adrenal Hyperplasia: a Retrospective Cohort Study

  2025cites this paper
• Crinecerfont: CRF1R Antagonist Approved for Treatment of Congenital Adrenal Hyperplasia.

  2025cites this paper
• 21-deoxycortisol as a second-tier test in congenital adrenal hyperplasia newborn screening in The Netherlands: two-year evaluation

  2025cites this paper
• ALDOSTERONE SYNTHASE DEFICIENCY FROM HOMOZYGOUS CYP11B2 MUTATION PRESENTING WITH SALT WASTING CRISIS AND FAILURE TO THRIVE IN AN INFANT

  2025cites this paper
• The Negotiation of Medical Treatments by Parents of Children with Congenital Adrenal Hyperplasia in Poland

  2025cites this paper
• Enhancing Accuracy of Newborn Screening for 21OHD: Strategic Use of 21-Deoxycortisol in a Large-Scale Tokyo Cohort.

  2025cites this paper
• Targeted editing of the 21-hydroxylase locus confers durable therapeutic effect in a murine model of congenital adrenal hyperplasia.

  2025cites this paper
• Non-classical congenital adrenal hyperplasia: current insights into clinical implications, diagnosis and treatment

  2025cites this paper
• Assessing cortisol levels in non-classical congenital adrenal hyperplasia: focus on the V281L variant

  2025cites this paper
• Research Advances in Biochemical and Genetic Testing for Congenital Adrenal Hyperplasia in Neonates

  2025cites this paper
• Classic 21‐hydroxylase deficiency in opposite‐sex twins

  2025cites this paper
• Exploration of the potential of genomic editing in the treatment of congenital adrenal hyperplasia

  2025cites this paper
• Mixed Gonadal Dysgenesis: A Comprehensive Review of Clinical Spectrum, Diagnostic Strategies, and Management Approaches

  2025cites this paper
• Transcript Patterns of Bovine CYP21A2 and Its Pseudogene in Adrenal and Ovarian Tissues

  2025cites this paper
• Identification of technically challenging variants: Whole-genome sequencing improves diagnostic yield in patients with high clinical suspicion of rare diseases

  2025cites this paper
• Severe Clinical Manifestation of a Salt Wasting Form of Congenital Adrenal Hyperplasia Harboring a Complex Genotype

  2025cites this paper
• Genetics in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency and Clinical Implications

  2025cites this paper
• Longitudinal 12-Month Follow-Up of a Male Infant with CYP21A2 Compound Heterozygous Genotype in China: A Case Report

  2025cites this paper
• Adrenal steroid hormone responses to exercise under thermal stress: Potential role for nonclassic congenital adrenal hyperplasia in heat illness susceptibility

  2025cites this paper
• Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women

  2025cites this paper
• Orthodontic Management of a Pediatric Patient Affected by Congenital Adrenal Hyperplasia: Case Report.

  2025cites this paper
• Modelling adrenal steroid profiles to inform monitoring guidance in congenital adrenal hyperplasia

  2025cites this paper
• When Hormones Shape the Mind: Neuropsychiatric Manifestations in a Patient With Congenital Adrenal Hyperplasia and Genital Ambiguity

  2025cites this paper
• Human Gonads Do Not Contribute to the Circulating Pool of 11-Oxygenated Androgens.

  2024cites this paper
• High carrier frequency of CYP21A2 gene mutations in Southern India – underscoring the need for genetic testing in Congenital Adrenal Hyperplasia

  2024cites this paper
• Case report: Development of central precocious puberty in a girl with late-diagnosed simple virilizing congenital adrenal hyperplasia complicated with Williams syndrome

  2024cites this paper
• Sex: the last real binary?

  2024cites this paper
• Genetic Disruption of cyp21a2 Leads to Systemic Glucocorticoid Deficiency and Tissues Hyperplasia in the Teleost Fish Medaka (Oryzias latipes)

  2024cites this paper
• From Rarity to Recognition: Infantile Botulism and the Broad Spectrum of Differential Diagnoses

  2024cites this paper
• Evidence of the Role of Inflammation and the Hormonal Environment in the Pathogenesis of Adrenal Myelolipomas in Congenital Adrenal Hyperplasia

  2024cites this paper
• Reference intervals for serum 11-oxygenated androgens in children.

  2024cites this paper
• Discovery of CRN04894: A Novel Potent Selective MC2R Antagonist.

  2024cites this paper
• Chimeric Genes Causing 11β-Hydroxylase Deficiency: Implications in Clinical and Molecular Diagnosis

  2024cites this paper
• Catalytic enhancements in cytochrome P450 2C19 by cytochrome b_5

  2024cites this paper
• Prenatal Androgen Exposure and Sex-Typical Play Behaviour: A Meta-Analysis of Classic Congenital Adrenal Hyperplasia Studies.

  2024cites this paper
• A CYP11A1 homozygous exonic variant inducing an alternative splicing, frameshift and truncation in a family with congenital adrenal hyperplasia

  2024cites this paper
• Neonatal reference intervals for serum steroid hormone concentrations measured by LC-MS/MS

  2024cites this paper
• Establishing the Cut-Off Values of 17-Hydroxyprogesterone for Diagnosing Congenital Adrenal Hyperplasia: A Prospective Observational Study in a Tertiary Care Hospital

  2024cites this paper
• Adrenal insufficiency - causes and laboratory diagnosis.

  2024cites this paper
• Genome editing in the adrenal gland: a novel strategy for treating congenital adrenal hyperplasia

  2024cites this paper
• Severe Hyperandrogenism in 46,XX Congenital Adrenal Hyperplasia: Molecular Physiopathology, Late Diagnoses, and Personalized Management

  2024cites this paper
• Current status and prospects of congenital adrenal hyperplasia: A bibliometric and visualization study

  2024cites this paper
• Genetics of 21-OH Deficiency and Genotype–Phenotype Correlation: Experience of the Hellenic National Referral Center

  2024cites this paper
• Case 1: Clitoromegaly, Oligomenorrhea, and Hirsutism in a 17-year-old Transgender Male.

  2024cites this paper
• 3D printed personalized therapies for pediatric patients affected by adrenal insufficiency

  2024cites this paper
• Adrenocortical tumors and hereditary syndromes

  2024cites this paper
• Клиническое наблюдение пациента с сочетанной эндокринной патологией: врожденной дисфункцией коры надпочечников и синдромом Клайнфельтера

  2024cites this paper
• Long-read sequencing solves complex structure of CYP21A2 in a large 21-hydroxylase deficiency cohort.

  2024cites this paper
• The spectrum of clinical, hormonal findings in children with congenital adrenal hyperplasia in Isfahan province; a 20-year review

  2024cites this paper
• Synchronous bilateral adrenalectomy for ACTH-independent Cushing's syndrome in children: multidisciplinary management.

  2024cites this paper
• Congenital Adrenal Hyperplasia – A Comprehensive Review of Genetic Studies on 21-Hydroxylase Deficiency from India

  2024cites this paper
• Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia

  2024cites this paper
• A Humanized and Viable Animal Model for Congenital Adrenal Hyperplasia–CYP21A2-R484Q Mutant Mouse

  2024cites this paper
• A patient with different sex development (DSD)

  2024cites this paper
• Challenging Molecular Diagnosis of Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency: Case Series and Novel Variants of CYP21A2 Gene

  2024cites this paper
• Renal Failure and Atypical Genital Appearance in a Critically Ill Infant

  2023cites this paper
• The impact of neonatal 17-hydroxyprogesterone cutoff determination in a public newborn screening program for congenital adrenal hyperplasia in Southern Brazil: 3 years’ experience

  2023cites this paper
• Effect of complete suppression of androstenedione on auxological development in prepubertal patients with classical congenital adrenal hyperplasia

  2023cites this paper
• Serum Steroid Profile Captures Metabolic Phenotypes in Adults with Classic Congenital Adrenal Hyperplasia.

  2023cites this paper
• A MinION-Based Long-Read Sequencing Application with One-Step PCR for the Genetic Diagnosis of 21-Hydroxylase Deficiency.

  2023cites this paper
• THE IMPORTANCE OF NEWBORN SCREENING FOR THE DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA: LITERATURE REVIEW

  2023cites this paper
• Effect of lairage time prior to slaughter on stress in pigs: a path analysis

  2023cites this paper
• Assessing treatment adherence is crucial to determine adequacy of mineralocorticoid therapy

  2023cites this paper
• Endocrine-Disrupting Chemicals and Hippocampal Development: The Role of Estrogen and Androgen Signaling

  2023cites this paper
• Clinical and Hormonal Profile of Classical 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia: Experience from a Tertiary Centre In India

  2023cites this paper
• Rare forms of congenital adrenal hyperplasia

  2023cites this paper
• Single-exon deletions of ZNRF3 exon 2 cause congenital adrenal hypoplasia

  2023cites this paper
• A rare occurrence of non-classic congenital adrenal hyperplasia and type 1 diabetes mellitus in a girl with Prader-Willi Syndrome: Case report and review of the literature

  2023cites this paper
• High carrier frequency of a nonsense p.Trp230* variant in HSD3B2 gene in Ossetians

  2023cites this paper
• Synthetic glucocorticoids instead of hydrocortisone do not increase mineralocorticoid needs in adult patients with salt wasting congenital adrenal hyperplasia.

  2023cites this paper
• An update on the long-term outcomes of prenatal dexamethasone treatment in congenital adrenal hyperplasia

  2023cites this paper
• Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess

  2023cites this paper
• Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

  2023influential citation
• Multiplexed Serum Steroid Profiling Reveals Metabolic Signatures of Subtypes in Congenital Adrenal Hyperplasia

  2023cites this paper
• Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia.

  2023cites this paper
• Characterization of a novel corticosterone response gene in Xenopus tropicalis tadpole tails

  2023cites this paper
• Continuous Glucose Monitoring in Children and Adolescents with Congenital Adrenal Hyperplasia

  2023cites this paper
• The pathogenic p.Gln319Ter variant is not causing congenital adrenal hyperplasia when inherited in one of the duplicated CYP21A2 genes

  2023cites this paper
• An updated clinico-investigative approach to diagnosis of cutaneous hyperandrogenism in relation to adult female acne, female pattern alopecia & hirsutism a primer for dermatologists

  2023cites this paper
• Evaluation of aggression level in adolescent girls with classical congenital adrenal hyperplasia

  2023cites this paper
• Current and future perspectives on clinical management of classic 21-hydroxylase deficiency.

  2023cites this paper
• Long-term 10-year comparison of girls with congenital adrenal hyperplasia who underwent early and late feminizing genitoplasty

  2023cites this paper
• Adrenal insufficiency due to high doses of maternal corticosteroid treatment in a premature baby

  2022cites this paper
• Devastating salt‐wasting crisis in a four‐month‐old male child with congenital adrenal hyperplasia, highlighting the essence of neonatal screening

  2022cites this paper
• Exploring Factors Associated with Decisions about Feminizing Genitoplasty in Differences of Sex Development.

  2022cites this paper
• Simultaneous quantitation of 17 endogenous adrenal corticosteroid hormones in human plasma by UHPLC-MS/MS and their application in congenital adrenal hyperplasia screening

  2022cites this paper
• Classic and backdoor pathways of androgen biosynthesis in human sexual development

  2022cites this paper
• Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)

  2022cites this paper
• Adrenal steroid profiling as a diagnostic tool to differentiate polycystic ovary syndrome from nonclassic congenital adrenal hyperplasia: pinpointing easy screening possibilities and normal cutoff levels using liquid chromatography tandem mass spectrometry.

  2022cites this paper
• Congenital Adrenal Hyperplasia and Brain Health: A Systematic Review of Structural, Functional, and Diffusion Magnetic Resonance Imaging (MRI) Investigations

  2022cites this paper
• Salt-Wasting Form of Congenital Adrenal Hyperplasia: A Case Report

  2022influential citation
• Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach

  2022cites this paper